Friday, 31 Oct 2025
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA
logo logo
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
  • đŸ”„
  • Trump
  • VIDEO
  • House
  • White
  • ScienceAlert
  • Trumps
  • Watch
  • man
  • Health
  • Season
Font ResizerAa
American FocusAmerican Focus
Search
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
Follow US
© 2024 americanfocus.online – All Rights Reserved.
American Focus > Blog > Tech and Science > A common drug may help treat a rare genetic disease
Tech and Science

A common drug may help treat a rare genetic disease

Last updated: November 8, 2024 11:15 pm
Share
A common drug may help treat a rare genetic disease
SHARE

A recent study presented at the American Society of Human Genetics annual meeting suggests that ibuprofen, a common drug found in almost every medicine cabinet, may hold promise as a treatment for a rare genetic disease known as MAN1B1-congenital disorder of glycosylation. This disease is caused by mutations in the MAN1B1 gene, which leads to developmental delays, obesity, aggression, distinctive facial features, and other health issues.

Geneticist Clement Chow and his team at the University of Utah conducted research on fruit flies with mutated MAN1B1 genes. The flies exhibited small and rough eyes as a result of the mutation. The researchers tested approximately 1,500 existing drugs on these flies and found that 51 drugs were able to restore the flies’ eyes to their normal state, while 47 drugs worsened the condition. Surprisingly, nine of the drugs that successfully restored the flies’ eyes were nonsteroidal anti-inflammatory drugs (NSAIDs), including ibuprofen.

Further investigation revealed that ibuprofen inhibits the activity of enzymes known as COX1 and COX2, which are involved in reducing inflammation in the body. In flies lacking MAN1B1, the activity of these enzymes was high, leading to abnormal eye shapes. By treating the flies with ibuprofen, the researchers were able to lower the enzyme activity and restore normal eye shapes, indicating a potential link between MAN1B1 and COX enzyme function.

Additionally, flies that completely lacked MAN1B1 experienced prolonged seizures when subjected to external stimuli. However, treatment with ibuprofen reduced the frequency of seizures in these flies, suggesting a neuroprotective effect of the drug in the absence of MAN1B1.

See also  Alzheimer's drug data, Congressional races

Based on the promising results from the fly experiments, a doctor initiated a trial with three children who have MAN1B1 mutations, administering low-dose ibuprofen as a potential treatment. While the results are still preliminary, early indications are positive, and further research is underway to explore the therapeutic potential of ibuprofen in treating MAN1B1-congenital disorder of glycosylation.

In conclusion, the study highlights the importance of drug repurposing research in finding new treatments for rare genetic diseases, offering hope for individuals living with these conditions who may not have access to conventional therapies. Ibuprofen, a widely available and commonly used drug, shows promise as a potential treatment for MAN1B1-related disorders, paving the way for future clinical trials and therapeutic interventions.

TAGGED:CommondiseaseDruggeneticRaretreat
Share This Article
Twitter Email Copy Link Print
Previous Article ‘Candyman’ Star Tony Todd Dead at 69 in Los Angeles ‘Candyman’ Star Tony Todd Dead at 69 in Los Angeles
Next Article States Must Step Up – Union of Concerned Scientists States Must Step Up – Union of Concerned Scientists
Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Popular Posts

A List Of Outdoor Games For Your Community Festival 

Community festivals are a great way to bring neighbours together, fostering connections and creating lasting…

November 6, 2024

Volcano Worlds Might Be the First Exomoons Found by Astronomers

Unique Article Title Captivating Headline for the Article In the ever-evolving landscape of digital technology,…

October 14, 2025

Fantasy Cricket Tips, Today’s Playing 11 and Pitch Report for West Indies Tour of England 2025, 1st T20I

The West Indies Tour of England 2025 is all set to kick off with an…

June 6, 2025

Drysdale finally buys house – but mayor not moving in yet

Tauranga Mayor MahĂ© Drysdale has recently purchased a home in Pāpāmoa, although he and his…

May 16, 2025

What worries media mogul Rogers

Former NBC Cable President Tom Rogers is dialing back his bullishness on Netflix, citing competition…

July 26, 2025

You Might Also Like

The New Scientist Book Club’s verdict on Our Brains, Our Selves: A mix of praise and misgivings
Tech and Science

The New Scientist Book Club’s verdict on Our Brains, Our Selves: A mix of praise and misgivings

October 31, 2025
Tech Advisor December 2025 Digital Magazine
Tech and Science

Tech Advisor December 2025 Digital Magazine

October 31, 2025
Scientists Identified a New Blood Group After a 50-Year Mystery : ScienceAlert
Tech and Science

Scientists Identified a New Blood Group After a 50-Year Mystery : ScienceAlert

October 31, 2025
Nanotyrannus Isn’t a Juvenile T-Rex—It’s a Separate Dinosaur
Tech and Science

Nanotyrannus Isn’t a Juvenile T-Rex—It’s a Separate Dinosaur

October 31, 2025
logo logo
Facebook Twitter Youtube

About US


Explore global affairs, political insights, and linguistic origins. Stay informed with our comprehensive coverage of world news, politics, and Lifestyle.

Top Categories
  • Crime
  • Environment
  • Sports
  • Tech and Science
Usefull Links
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA

© 2024 americanfocus.online –  All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?